Agilent to acquire Biocare Medical for $950 million
March 9, 2026—Agilent Technologies has entered into a definitive agreement to acquire Biocare Medical in an all-cash transaction valued at $950 million.
Webinars and Sponsored Roundtables — Register Now
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Industry News
Proscia earns top score in KLAS digital pathology report
March 4, 2026—A new report from KLAS Research awarded Proscia the highest overall performance score (95.2) in the U.S. market, based on customer feedback.
ARUP creates Innovation Central Laboratory
Feb. 26, 2026—ARUP Laboratories has launched the Innovation Central Laboratory to facilitate collaboration with pharmaceutical, biotechnology, and other industry partners.
Labcorp to deploy FDA-cleared AISight Dx nationwide
Feb. 25, 2026—Labcorp is expanding its collaboration with PathAI to deploy PathAI’s AISight Dx, an FDA-cleared digital pathology platform, across its anatomic pathology labs and hospital collaborations.
Exa Capital acquires health care workforce platform StaffReady
Feb. 24, 2026—Exa Capital has acquired StaffReady, an SaaS platform for managing clinical workforces in health care.
Copan’s PhenoMatrix software gets FDA 510(k) clearance
Feb. 23, 2026—Copan Group’s PhenoMatrix, an automated image assessment software used with the company’s WASPLab laboratory automation platform, received FDA 510(k) clearance as a class II device.
Arlington Scientific acquires ELISA product line
Feb. 20, 2026—Arlington Scientific has completed its acquisition of Awareness Technology’s EIA/ELISA product line.
ABPath updates its retired status for diplomates
Feb. 19, 2026—The American Board of Pathology is updating how diplomate status will be recorded for people no longer in active practice.
Hardy Dx gets breakthrough designation for AMR assays
Feb. 18, 2026—The Food and Drug Administration has granted breakthrough device designation to the NG-Test Candida auris and NG-Test Acineto-5 assays.
FDA clears Cepheid Xpert GI multiplex PCR test
Feb. 17, 2026—Cepheid received FDA clearance for its Xpert GI panel, a multiplex PCR test designed to detect gastrointestinal pathogens from a single patient sample.